Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 51
  • Journal CiteScore: 10.69
  • Journal Impact Factor: 9.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


A Short Review on the Current Status of Coronavirus Disease 2019

Debashish Paramanick

Corona viruses (Co-V) are known as respiratory pathogen leading to a serious pandemic such as serious acute respiratory problems (SARS), the Middle East respiratory syndrome ï¼ÂˆMERSï¼Âˆ and corona virus disease 2019ï¼ÂˆCOVID-19). The World Health Organization (WHO) has acknowledged that recent outbreak as a global public health emergency. Now coronavirus has spread in 213 countries. There are approximately 4740536 confirmed cases and 313641 deaths in worldwide. India had total 17378 active cases till 24th of April 2020. The study on novel coronavirus is still in the primary stage. Based on the current data, we summarize the epidemiology, clinical characteristics, pathogenesis, diagnosis, treatment and prevention of information regarding COVID-19. In this mini-review, we focused at inspecting the most recent trend of COVID-19 for helping the community recognize and deal with the 2019 novel coronavirus (SARS-Co-V-2019), some antiviral medicine like Lopinavir, Ribavirin, Chloroquine Phosphate is using for treatment of COVID-19 and providing a reference for forthcoming studies.